The peptide modulates nitric oxide synthesis, which governs vascular tone, blood flow, and inflammatory responses across gut, muscle, and neural tissue
These apply to Wegovy, Mounjaro, and other GLP-1 medications as a class
Unresolved safety questions The staff review identified uncertainty about immunogenicity, aggregation, peptide-related impurities, hypersensitivity, route-specific risk, repeated exposure, and long-term use
Cycle Length and Best Practices Since AOD-9604 is not a growth-promoting hormone and does not elevate IGF-1, its dosing protocols are generally designed for short to moderate cycles rather than continuous long-term use
The iceberg nature of fibromyalgia burden: the clinical and economic aspects